Effective prediction of IL-17 inducing peptides using hybrid approach: iIL17pred

Read the full article See related articles

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Background

Interleukin 17 (IL-17) plays a crucial role in regulating the immune system and is associated with numerous diseases. Modulating IL-17 levels has demonstrated potential in mitigating disease symptoms, positioning it as a compelling target for drug development. Therefore, identifying and characterizing novel drug molecules capable of influencing IL-17 levels is critical. Recent advances in therapeutic peptides underscore their promise as attractive drug candidates, inspiring the development of IL-17 modulating peptides.

Results

This study aimed to enhance existing methods for efficiently classifying IL-17 inducing peptides. Positive and negative datasets were obtained from the Immune Epitope Database, and peptide features were extracted using the pfeature algorithm. A three-stage hybrid approach combining BLAST, MERCI, and machine learning techniques was employed to accurately classify IL-17-inducing peptides.

Conclusions

Extensive benchmarking experiments revealed that our proposed method outperforms existing techniques i.e IL17eScan, across key performance metrics, including sensitivity, accuracy, and area under the curve-receiver operating characteristics (AUC-ROC). Our algorithm achieved an accuracy of 88.08% and a Matthews Correlation Coefficient (MCC) of 0.68 on an external dataset, significantly surpassing the accuracy of 78.57% and MCC of 0.57 achieved by existing methods under comparable conditions. This demonstrates a substantial improvement in IL-17 peptide classification. The results are accessible via a user-friendly web server ( http://www.soodlab.com/iil17pred/ ). These findings hold significant potential for predicting IL-17-inducing peptides, which can be further validated experimentally.

Article activity feed